nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—ulcerative colitis—colon cancer	0.536	1	CtDrD
Betamethasone—PTGS2—colon cancer	0.176	0.54	CbGaD
Betamethasone—ABCB1—colon cancer	0.15	0.46	CbGaD
Betamethasone—ABCB1—Irinotecan—colon cancer	0.00373	0.284	CbGbCtD
Betamethasone—PLA2G1B—blood vessel—colon cancer	0.00329	0.12	CbGeAlD
Betamethasone—ABCB1—Vincristine—colon cancer	0.00326	0.248	CbGbCtD
Betamethasone—CYP3A4—Irinotecan—colon cancer	0.00223	0.17	CbGbCtD
Betamethasone—ABCB1—Methotrexate—colon cancer	0.00197	0.15	CbGbCtD
Betamethasone—CYP3A4—Vincristine—colon cancer	0.00195	0.149	CbGbCtD
Betamethasone—PLA2G1B—epithelium—colon cancer	0.0016	0.0583	CbGeAlD
Betamethasone—PGR—blood vessel—colon cancer	0.00151	0.0551	CbGeAlD
Betamethasone—PLA2G1B—renal system—colon cancer	0.00148	0.054	CbGeAlD
Betamethasone—PLA2G1B—digestive system—colon cancer	0.00122	0.0443	CbGeAlD
Betamethasone—PTGS2—endothelium—colon cancer	0.000819	0.0298	CbGeAlD
Betamethasone—NR3C2—smooth muscle tissue—colon cancer	0.000764	0.0278	CbGeAlD
Betamethasone—PTGS2—blood vessel—colon cancer	0.000756	0.0275	CbGeAlD
Betamethasone—PGR—epithelium—colon cancer	0.000737	0.0268	CbGeAlD
Betamethasone—NR3C2—renal system—colon cancer	0.000735	0.0268	CbGeAlD
Betamethasone—PTGS2—gall bladder—colon cancer	0.000711	0.0259	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—colon cancer	0.00071	0.0258	CbGeAlD
Betamethasone—NR3C2—digestive system—colon cancer	0.000603	0.022	CbGeAlD
Betamethasone—PGR—lymphoid tissue—colon cancer	0.000567	0.0207	CbGeAlD
Betamethasone—NR3C2—vagina—colon cancer	0.000532	0.0194	CbGeAlD
Betamethasone—NR3C1—embryo—colon cancer	0.000521	0.019	CbGeAlD
Betamethasone—PGR—vagina—colon cancer	0.000495	0.018	CbGeAlD
Betamethasone—ABCB1—blood vessel—colon cancer	0.000467	0.017	CbGeAlD
Betamethasone—PTGS2—embryo—colon cancer	0.000451	0.0164	CbGeAlD
Betamethasone—NR3C2—liver—colon cancer	0.000449	0.0164	CbGeAlD
Betamethasone—NR3C1—epithelium—colon cancer	0.000425	0.0155	CbGeAlD
Betamethasone—NR3C1—smooth muscle tissue—colon cancer	0.00041	0.0149	CbGeAlD
Betamethasone—NR3C1—renal system—colon cancer	0.000394	0.0144	CbGeAlD
Betamethasone—CYP19A1—liver—colon cancer	0.000376	0.0137	CbGeAlD
Betamethasone—PTGS2—epithelium—colon cancer	0.000368	0.0134	CbGeAlD
Betamethasone—PTGS2—smooth muscle tissue—colon cancer	0.000354	0.0129	CbGeAlD
Betamethasone—NR3C2—lymph node—colon cancer	0.000344	0.0125	CbGeAlD
Betamethasone—PTGS2—renal system—colon cancer	0.000341	0.0124	CbGeAlD
Betamethasone—NR3C1—lymphoid tissue—colon cancer	0.000327	0.0119	CbGeAlD
Betamethasone—NR3C1—digestive system—colon cancer	0.000323	0.0118	CbGeAlD
Betamethasone—PGR—lymph node—colon cancer	0.00032	0.0117	CbGeAlD
Betamethasone—CYP3A4—renal system—colon cancer	0.000298	0.0109	CbGeAlD
Betamethasone—NR3C1—bone marrow—colon cancer	0.000298	0.0109	CbGeAlD
Betamethasone—CYP19A1—lymph node—colon cancer	0.000288	0.0105	CbGeAlD
Betamethasone—NR3C1—vagina—colon cancer	0.000286	0.0104	CbGeAlD
Betamethasone—PTGS2—lymphoid tissue—colon cancer	0.000283	0.0103	CbGeAlD
Betamethasone—PTGS2—digestive system—colon cancer	0.00028	0.0102	CbGeAlD
Betamethasone—ABCB1—embryo—colon cancer	0.000279	0.0102	CbGeAlD
Betamethasone—PTGS2—bone marrow—colon cancer	0.000258	0.00939	CbGeAlD
Betamethasone—PTGS2—vagina—colon cancer	0.000247	0.009	CbGeAlD
Betamethasone—CYP3A4—digestive system—colon cancer	0.000245	0.0089	CbGeAlD
Betamethasone—NR3C1—liver—colon cancer	0.000241	0.00877	CbGeAlD
Betamethasone—ABCB1—epithelium—colon cancer	0.000228	0.00829	CbGeAlD
Betamethasone—Weight decreased—Vincristine—colon cancer	0.000217	0.00284	CcSEcCtD
Betamethasone—Extravasation—Methotrexate—colon cancer	0.000212	0.00278	CcSEcCtD
Betamethasone—Weight decreased—Irinotecan—colon cancer	0.000211	0.00277	CcSEcCtD
Betamethasone—ABCB1—renal system—colon cancer	0.000211	0.00768	CbGeAlD
Betamethasone—Acute coronary syndrome—Vincristine—colon cancer	0.000211	0.00276	CcSEcCtD
Betamethasone—Myocardial infarction—Vincristine—colon cancer	0.000209	0.00275	CcSEcCtD
Betamethasone—Neuropathy peripheral—Vincristine—colon cancer	0.000209	0.00275	CcSEcCtD
Betamethasone—Thrombophlebitis—Capecitabine—colon cancer	0.000209	0.00274	CcSEcCtD
Betamethasone—PTGS2—liver—colon cancer	0.000208	0.00759	CbGeAlD
Betamethasone—Diabetes mellitus—Capecitabine—colon cancer	0.000208	0.00272	CcSEcCtD
Betamethasone—Acute coronary syndrome—Irinotecan—colon cancer	0.000205	0.00269	CcSEcCtD
Betamethasone—Myocardial infarction—Irinotecan—colon cancer	0.000204	0.00267	CcSEcCtD
Betamethasone—Herpes simplex—Methotrexate—colon cancer	0.000201	0.00264	CcSEcCtD
Betamethasone—Eye pain—Capecitabine—colon cancer	0.0002	0.00262	CcSEcCtD
Betamethasone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000196	0.00258	CcSEcCtD
Betamethasone—Ulcer—Methotrexate—colon cancer	0.000196	0.00257	CcSEcCtD
Betamethasone—Myocardial infarction—Fluorouracil—colon cancer	0.000195	0.00256	CcSEcCtD
Betamethasone—Neuropathy peripheral—Fluorouracil—colon cancer	0.000195	0.00256	CcSEcCtD
Betamethasone—Conjunctivitis—Fluorouracil—colon cancer	0.000194	0.00254	CcSEcCtD
Betamethasone—Increased appetite—Capecitabine—colon cancer	0.000192	0.00252	CcSEcCtD
Betamethasone—Hallucination—Vincristine—colon cancer	0.000191	0.0025	CcSEcCtD
Betamethasone—Bradycardia—Irinotecan—colon cancer	0.00019	0.00249	CcSEcCtD
Betamethasone—Vasculitis—Methotrexate—colon cancer	0.00019	0.00249	CcSEcCtD
Betamethasone—Dermatitis bullous—Capecitabine—colon cancer	0.000189	0.00248	CcSEcCtD
Betamethasone—Haemoglobin—Irinotecan—colon cancer	0.000188	0.00246	CcSEcCtD
Betamethasone—Haemorrhage—Irinotecan—colon cancer	0.000187	0.00245	CcSEcCtD
Betamethasone—Cardiac failure—Capecitabine—colon cancer	0.000185	0.00243	CcSEcCtD
Betamethasone—NR3C1—lymph node—colon cancer	0.000185	0.00673	CbGeAlD
Betamethasone—Lethargy—Capecitabine—colon cancer	0.000184	0.00242	CcSEcCtD
Betamethasone—CYP3A4—liver—colon cancer	0.000182	0.00663	CbGeAlD
Betamethasone—Osteoarthritis—Capecitabine—colon cancer	0.000181	0.00237	CcSEcCtD
Betamethasone—Visual impairment—Irinotecan—colon cancer	0.00018	0.00236	CcSEcCtD
Betamethasone—Haemoglobin—Fluorouracil—colon cancer	0.00018	0.00236	CcSEcCtD
Betamethasone—Haemorrhage—Fluorouracil—colon cancer	0.000179	0.00235	CcSEcCtD
Betamethasone—Migraine—Capecitabine—colon cancer	0.000178	0.00233	CcSEcCtD
Betamethasone—Skin exfoliation—Methotrexate—colon cancer	0.000177	0.00232	CcSEcCtD
Betamethasone—ABCB1—lymphoid tissue—colon cancer	0.000175	0.00638	CbGeAlD
Betamethasone—Angiopathy—Vincristine—colon cancer	0.000174	0.00228	CcSEcCtD
Betamethasone—ABCB1—digestive system—colon cancer	0.000173	0.0063	CbGeAlD
Betamethasone—Irritability—Capecitabine—colon cancer	0.000172	0.00226	CcSEcCtD
Betamethasone—Cardiac arrest—Capecitabine—colon cancer	0.000172	0.00225	CcSEcCtD
Betamethasone—Mood swings—Capecitabine—colon cancer	0.000171	0.00224	CcSEcCtD
Betamethasone—Alopecia—Vincristine—colon cancer	0.000169	0.00222	CcSEcCtD
Betamethasone—Angiopathy—Irinotecan—colon cancer	0.000169	0.00222	CcSEcCtD
Betamethasone—Ecchymosis—Methotrexate—colon cancer	0.000168	0.0022	CcSEcCtD
Betamethasone—Arrhythmia—Irinotecan—colon cancer	0.000167	0.00219	CcSEcCtD
Betamethasone—Dry skin—Capecitabine—colon cancer	0.000166	0.00217	CcSEcCtD
Betamethasone—Alopecia—Irinotecan—colon cancer	0.000165	0.00216	CcSEcCtD
Betamethasone—Pulmonary oedema—Methotrexate—colon cancer	0.000165	0.00216	CcSEcCtD
Betamethasone—Hypokalaemia—Capecitabine—colon cancer	0.000164	0.00216	CcSEcCtD
Betamethasone—PTGS2—lymph node—colon cancer	0.00016	0.00582	CbGeAlD
Betamethasone—Arrhythmia—Fluorouracil—colon cancer	0.00016	0.0021	CcSEcCtD
Betamethasone—ABCB1—bone marrow—colon cancer	0.00016	0.00581	CbGeAlD
Betamethasone—Muscular weakness—Capecitabine—colon cancer	0.000159	0.00209	CcSEcCtD
Betamethasone—Alopecia—Fluorouracil—colon cancer	0.000158	0.00207	CcSEcCtD
Betamethasone—Erythema—Fluorouracil—colon cancer	0.000156	0.00204	CcSEcCtD
Betamethasone—Thrombophlebitis—Methotrexate—colon cancer	0.000155	0.00204	CcSEcCtD
Betamethasone—Diabetes mellitus—Methotrexate—colon cancer	0.000155	0.00203	CcSEcCtD
Betamethasone—ABCB1—vagina—colon cancer	0.000153	0.00557	CbGeAlD
Betamethasone—Sweating increased—Capecitabine—colon cancer	0.000152	0.00199	CcSEcCtD
Betamethasone—Ill-defined disorder—Irinotecan—colon cancer	0.000151	0.00198	CcSEcCtD
Betamethasone—Vertigo—Vincristine—colon cancer	0.00015	0.00197	CcSEcCtD
Betamethasone—Malaise—Irinotecan—colon cancer	0.000147	0.00192	CcSEcCtD
Betamethasone—Vertigo—Irinotecan—colon cancer	0.000146	0.00192	CcSEcCtD
Betamethasone—Syncope—Irinotecan—colon cancer	0.000146	0.00191	CcSEcCtD
Betamethasone—Convulsion—Vincristine—colon cancer	0.000145	0.0019	CcSEcCtD
Betamethasone—Hypertension—Vincristine—colon cancer	0.000144	0.00189	CcSEcCtD
Betamethasone—Loss of consciousness—Irinotecan—colon cancer	0.000143	0.00187	CcSEcCtD
Betamethasone—Myalgia—Vincristine—colon cancer	0.000142	0.00186	CcSEcCtD
Betamethasone—Weight increased—Capecitabine—colon cancer	0.000142	0.00186	CcSEcCtD
Betamethasone—Visual disturbance—Methotrexate—colon cancer	0.000142	0.00186	CcSEcCtD
Betamethasone—Weight decreased—Capecitabine—colon cancer	0.000141	0.00185	CcSEcCtD
Betamethasone—Hyperglycaemia—Capecitabine—colon cancer	0.000141	0.00185	CcSEcCtD
Betamethasone—Hypertension—Irinotecan—colon cancer	0.00014	0.00184	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000139	0.00182	CcSEcCtD
Betamethasone—Acute coronary syndrome—Capecitabine—colon cancer	0.000137	0.0018	CcSEcCtD
Betamethasone—Lethargy—Methotrexate—colon cancer	0.000137	0.0018	CcSEcCtD
Betamethasone—Discomfort—Irinotecan—colon cancer	0.000137	0.00179	CcSEcCtD
Betamethasone—Myocardial infarction—Capecitabine—colon cancer	0.000136	0.00179	CcSEcCtD
Betamethasone—Neuropathy peripheral—Capecitabine—colon cancer	0.000136	0.00179	CcSEcCtD
Betamethasone—Oedema—Vincristine—colon cancer	0.000136	0.00179	CcSEcCtD
Betamethasone—Anaphylactic shock—Vincristine—colon cancer	0.000136	0.00179	CcSEcCtD
Betamethasone—Infection—Vincristine—colon cancer	0.000135	0.00177	CcSEcCtD
Betamethasone—Conjunctivitis—Capecitabine—colon cancer	0.000135	0.00177	CcSEcCtD
Betamethasone—Convulsion—Fluorouracil—colon cancer	0.000135	0.00177	CcSEcCtD
Betamethasone—Osteoarthritis—Methotrexate—colon cancer	0.000134	0.00176	CcSEcCtD
Betamethasone—Nervous system disorder—Vincristine—colon cancer	0.000134	0.00175	CcSEcCtD
Betamethasone—Thrombocytopenia—Vincristine—colon cancer	0.000133	0.00175	CcSEcCtD
Betamethasone—Anaphylactic shock—Irinotecan—colon cancer	0.000133	0.00174	CcSEcCtD
Betamethasone—Oedema—Irinotecan—colon cancer	0.000133	0.00174	CcSEcCtD
Betamethasone—Myalgia—Fluorouracil—colon cancer	0.000133	0.00174	CcSEcCtD
Betamethasone—Infection—Irinotecan—colon cancer	0.000132	0.00173	CcSEcCtD
Betamethasone—Hyperhidrosis—Vincristine—colon cancer	0.000132	0.00173	CcSEcCtD
Betamethasone—Discomfort—Fluorouracil—colon cancer	0.000131	0.00172	CcSEcCtD
Betamethasone—Fluticasone furoate—ABCB1—colon cancer	0.000131	0.205	CrCbGaD
Betamethasone—Shock—Irinotecan—colon cancer	0.000131	0.00171	CcSEcCtD
Betamethasone—Nervous system disorder—Irinotecan—colon cancer	0.00013	0.00171	CcSEcCtD
Betamethasone—Thrombocytopenia—Irinotecan—colon cancer	0.00013	0.0017	CcSEcCtD
Betamethasone—Anorexia—Vincristine—colon cancer	0.00013	0.0017	CcSEcCtD
Betamethasone—ABCB1—liver—colon cancer	0.000129	0.0047	CbGeAlD
Betamethasone—Irritability—Methotrexate—colon cancer	0.000128	0.00168	CcSEcCtD
Betamethasone—Hyperhidrosis—Irinotecan—colon cancer	0.000128	0.00168	CcSEcCtD
Betamethasone—Mood swings—Methotrexate—colon cancer	0.000127	0.00167	CcSEcCtD
Betamethasone—Hypotension—Vincristine—colon cancer	0.000127	0.00167	CcSEcCtD
Betamethasone—Bradycardia—Capecitabine—colon cancer	0.000127	0.00167	CcSEcCtD
Betamethasone—Anaphylactic shock—Fluorouracil—colon cancer	0.000127	0.00167	CcSEcCtD
Betamethasone—Oedema—Fluorouracil—colon cancer	0.000127	0.00167	CcSEcCtD
Betamethasone—Anorexia—Irinotecan—colon cancer	0.000126	0.00166	CcSEcCtD
Betamethasone—Infection—Fluorouracil—colon cancer	0.000126	0.00166	CcSEcCtD
Betamethasone—Haemoglobin—Capecitabine—colon cancer	0.000126	0.00165	CcSEcCtD
Betamethasone—Haemorrhage—Capecitabine—colon cancer	0.000125	0.00164	CcSEcCtD
Betamethasone—Nervous system disorder—Fluorouracil—colon cancer	0.000125	0.00163	CcSEcCtD
Betamethasone—Thrombocytopenia—Fluorouracil—colon cancer	0.000124	0.00163	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000124	0.00163	CcSEcCtD
Betamethasone—Tachycardia—Fluorouracil—colon cancer	0.000124	0.00163	CcSEcCtD
Betamethasone—Hypotension—Irinotecan—colon cancer	0.000124	0.00163	CcSEcCtD
Betamethasone—Insomnia—Vincristine—colon cancer	0.000123	0.00162	CcSEcCtD
Betamethasone—Paraesthesia—Vincristine—colon cancer	0.000122	0.0016	CcSEcCtD
Betamethasone—Anorexia—Fluorouracil—colon cancer	0.000121	0.00159	CcSEcCtD
Betamethasone—Visual impairment—Capecitabine—colon cancer	0.00012	0.00158	CcSEcCtD
Betamethasone—Insomnia—Irinotecan—colon cancer	0.00012	0.00157	CcSEcCtD
Betamethasone—Paraesthesia—Irinotecan—colon cancer	0.000119	0.00156	CcSEcCtD
Betamethasone—Hypotension—Fluorouracil—colon cancer	0.000119	0.00156	CcSEcCtD
Betamethasone—Decreased appetite—Vincristine—colon cancer	0.000118	0.00155	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vincristine—colon cancer	0.000118	0.00154	CcSEcCtD
Betamethasone—Fatigue—Vincristine—colon cancer	0.000117	0.00154	CcSEcCtD
Betamethasone—Eye disorder—Capecitabine—colon cancer	0.000117	0.00153	CcSEcCtD
Betamethasone—Dyspepsia—Irinotecan—colon cancer	0.000117	0.00153	CcSEcCtD
Betamethasone—Pain—Vincristine—colon cancer	0.000116	0.00153	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000116	0.00152	CcSEcCtD
Betamethasone—Decreased appetite—Irinotecan—colon cancer	0.000115	0.00151	CcSEcCtD
Betamethasone—Insomnia—Fluorouracil—colon cancer	0.000115	0.00151	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000115	0.0015	CcSEcCtD
Betamethasone—Fatigue—Irinotecan—colon cancer	0.000114	0.0015	CcSEcCtD
Betamethasone—Paraesthesia—Fluorouracil—colon cancer	0.000114	0.0015	CcSEcCtD
Betamethasone—Pain—Irinotecan—colon cancer	0.000113	0.00149	CcSEcCtD
Betamethasone—Angiopathy—Capecitabine—colon cancer	0.000113	0.00149	CcSEcCtD
Betamethasone—Dyspepsia—Fluorouracil—colon cancer	0.000112	0.00147	CcSEcCtD
Betamethasone—Arrhythmia—Capecitabine—colon cancer	0.000112	0.00146	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vincristine—colon cancer	0.000111	0.00146	CcSEcCtD
Betamethasone—Decreased appetite—Fluorouracil—colon cancer	0.00011	0.00145	CcSEcCtD
Betamethasone—Alopecia—Capecitabine—colon cancer	0.00011	0.00145	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00011	0.00144	CcSEcCtD
Betamethasone—Feeling abnormal—Irinotecan—colon cancer	0.000109	0.00143	CcSEcCtD
Betamethasone—Erythema—Capecitabine—colon cancer	0.000109	0.00143	CcSEcCtD
Betamethasone—Pain—Fluorouracil—colon cancer	0.000109	0.00142	CcSEcCtD
Betamethasone—Gastrointestinal pain—Irinotecan—colon cancer	0.000108	0.00142	CcSEcCtD
Betamethasone—Abdominal pain—Vincristine—colon cancer	0.000108	0.00141	CcSEcCtD
Betamethasone—Body temperature increased—Vincristine—colon cancer	0.000108	0.00141	CcSEcCtD
Betamethasone—Body temperature increased—Irinotecan—colon cancer	0.000105	0.00138	CcSEcCtD
Betamethasone—Abdominal pain—Irinotecan—colon cancer	0.000105	0.00138	CcSEcCtD
Betamethasone—Feeling abnormal—Fluorouracil—colon cancer	0.000105	0.00137	CcSEcCtD
Betamethasone—Methylprednisolone—ABCB1—colon cancer	0.000104	0.163	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—colon cancer	0.000103	0.162	CrCbGaD
Betamethasone—Ill-defined disorder—Capecitabine—colon cancer	0.000101	0.00132	CcSEcCtD
Betamethasone—Urticaria—Fluorouracil—colon cancer	0.000101	0.00132	CcSEcCtD
Betamethasone—Conjunctivitis—Methotrexate—colon cancer	0.000101	0.00132	CcSEcCtD
Betamethasone—Body temperature increased—Fluorouracil—colon cancer	0.0001	0.00132	CcSEcCtD
Betamethasone—ABCB1—lymph node—colon cancer	9.89e-05	0.0036	CbGeAlD
Betamethasone—Malaise—Capecitabine—colon cancer	9.81e-05	0.00129	CcSEcCtD
Betamethasone—Vertigo—Capecitabine—colon cancer	9.77e-05	0.00128	CcSEcCtD
Betamethasone—Asthenia—Vincristine—colon cancer	9.77e-05	0.00128	CcSEcCtD
Betamethasone—Syncope—Capecitabine—colon cancer	9.76e-05	0.00128	CcSEcCtD
Betamethasone—Loss of consciousness—Capecitabine—colon cancer	9.56e-05	0.00125	CcSEcCtD
Betamethasone—Asthenia—Irinotecan—colon cancer	9.52e-05	0.00125	CcSEcCtD
Betamethasone—Hypertension—Capecitabine—colon cancer	9.39e-05	0.00123	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—colon cancer	9.35e-05	0.00123	CcSEcCtD
Betamethasone—Diarrhoea—Vincristine—colon cancer	9.32e-05	0.00122	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—colon cancer	9.3e-05	0.00122	CcSEcCtD
Betamethasone—Myalgia—Capecitabine—colon cancer	9.26e-05	0.00121	CcSEcCtD
Betamethasone—Anxiety—Capecitabine—colon cancer	9.23e-05	0.00121	CcSEcCtD
Betamethasone—Discomfort—Capecitabine—colon cancer	9.15e-05	0.0012	CcSEcCtD
Betamethasone—Diarrhoea—Irinotecan—colon cancer	9.08e-05	0.00119	CcSEcCtD
Betamethasone—Dizziness—Vincristine—colon cancer	9.01e-05	0.00118	CcSEcCtD
Betamethasone—Pruritus—Fluorouracil—colon cancer	8.99e-05	0.00118	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—colon cancer	8.97e-05	0.00118	CcSEcCtD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	8.94e-05	0.00462	CbGpPWpGaD
Betamethasone—Oedema—Capecitabine—colon cancer	8.88e-05	0.00116	CcSEcCtD
Betamethasone—Infection—Capecitabine—colon cancer	8.82e-05	0.00116	CcSEcCtD
Betamethasone—Dizziness—Irinotecan—colon cancer	8.77e-05	0.00115	CcSEcCtD
Betamethasone—Shock—Capecitabine—colon cancer	8.74e-05	0.00115	CcSEcCtD
Betamethasone—Nervous system disorder—Capecitabine—colon cancer	8.71e-05	0.00114	CcSEcCtD
Betamethasone—NR3C1—Endoderm Differentiation—APC—colon cancer	8.7e-05	0.00449	CbGpPWpGaD
Betamethasone—Eye disorder—Methotrexate—colon cancer	8.69e-05	0.00114	CcSEcCtD
Betamethasone—Diarrhoea—Fluorouracil—colon cancer	8.69e-05	0.00114	CcSEcCtD
Betamethasone—Thrombocytopenia—Capecitabine—colon cancer	8.69e-05	0.00114	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	8.69e-05	0.00449	CbGpPWpGaD
Betamethasone—Tachycardia—Capecitabine—colon cancer	8.67e-05	0.00114	CcSEcCtD
Betamethasone—Vomiting—Vincristine—colon cancer	8.66e-05	0.00114	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—FGFR3—colon cancer	8.61e-05	0.00445	CbGpPWpGaD
Betamethasone—Rash—Vincristine—colon cancer	8.59e-05	0.00113	CcSEcCtD
Betamethasone—Hyperhidrosis—Capecitabine—colon cancer	8.58e-05	0.00113	CcSEcCtD
Betamethasone—Dermatitis—Vincristine—colon cancer	8.58e-05	0.00113	CcSEcCtD
Betamethasone—Headache—Vincristine—colon cancer	8.53e-05	0.00112	CcSEcCtD
Betamethasone—Anorexia—Capecitabine—colon cancer	8.46e-05	0.00111	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—colon cancer	8.44e-05	0.00111	CcSEcCtD
Betamethasone—Vomiting—Irinotecan—colon cancer	8.44e-05	0.00111	CcSEcCtD
Betamethasone—Dizziness—Fluorouracil—colon cancer	8.4e-05	0.0011	CcSEcCtD
Betamethasone—Rash—Irinotecan—colon cancer	8.37e-05	0.0011	CcSEcCtD
Betamethasone—Dermatitis—Irinotecan—colon cancer	8.36e-05	0.0011	CcSEcCtD
Betamethasone—Headache—Irinotecan—colon cancer	8.31e-05	0.00109	CcSEcCtD
Betamethasone—Hypotension—Capecitabine—colon cancer	8.3e-05	0.00109	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—colon cancer	8.22e-05	0.00108	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	8.14e-05	0.0042	CbGpPWpGaD
Betamethasone—Erythema—Methotrexate—colon cancer	8.1e-05	0.00106	CcSEcCtD
Betamethasone—Nausea—Vincristine—colon cancer	8.09e-05	0.00106	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Capecitabine—colon cancer	8.09e-05	0.00106	CcSEcCtD
Betamethasone—Vomiting—Fluorouracil—colon cancer	8.08e-05	0.00106	CcSEcCtD
Betamethasone—Insomnia—Capecitabine—colon cancer	8.03e-05	0.00105	CcSEcCtD
Betamethasone—Rash—Fluorouracil—colon cancer	8.01e-05	0.00105	CcSEcCtD
Betamethasone—Dermatitis—Fluorouracil—colon cancer	8e-05	0.00105	CcSEcCtD
Betamethasone—Paraesthesia—Capecitabine—colon cancer	7.97e-05	0.00105	CcSEcCtD
Betamethasone—Prednisone—ABCB1—colon cancer	7.97e-05	0.125	CrCbGaD
Betamethasone—Headache—Fluorouracil—colon cancer	7.96e-05	0.00104	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	7.92e-05	0.00409	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—AKT1—colon cancer	7.88e-05	0.00407	CbGpPWpGaD
Betamethasone—Nausea—Irinotecan—colon cancer	7.88e-05	0.00103	CcSEcCtD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.85e-05	0.00406	CbGpPWpGaD
Betamethasone—Dyspepsia—Capecitabine—colon cancer	7.82e-05	0.00103	CcSEcCtD
Betamethasone—Decreased appetite—Capecitabine—colon cancer	7.72e-05	0.00101	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Capecitabine—colon cancer	7.67e-05	0.00101	CcSEcCtD
Betamethasone—Fatigue—Capecitabine—colon cancer	7.66e-05	0.001	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	7.62e-05	0.00394	CbGpPWpGaD
Betamethasone—Pain—Capecitabine—colon cancer	7.59e-05	0.000996	CcSEcCtD
Betamethasone—Nausea—Fluorouracil—colon cancer	7.55e-05	0.00099	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—colon cancer	7.51e-05	0.000985	CcSEcCtD
Betamethasone—Prednisolone—ABCB1—colon cancer	7.35e-05	0.115	CrCbGaD
Betamethasone—Feeling abnormal—Capecitabine—colon cancer	7.32e-05	0.00096	CcSEcCtD
Betamethasone—Malaise—Methotrexate—colon cancer	7.3e-05	0.000958	CcSEcCtD
Betamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.3e-05	0.00377	CbGpPWpGaD
Betamethasone—Vertigo—Methotrexate—colon cancer	7.28e-05	0.000954	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—HNF4A—colon cancer	7.27e-05	0.00376	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Capecitabine—colon cancer	7.26e-05	0.000952	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—PIK3CA—colon cancer	7.16e-05	0.0037	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	7.1e-05	0.00366	CbGpPWpGaD
Betamethasone—Urticaria—Capecitabine—colon cancer	7.05e-05	0.000925	CcSEcCtD
Betamethasone—Abdominal pain—Capecitabine—colon cancer	7.02e-05	0.000921	CcSEcCtD
Betamethasone—Body temperature increased—Capecitabine—colon cancer	7.02e-05	0.000921	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—colon cancer	7.02e-05	0.00092	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CA7—colon cancer	6.96e-05	0.00359	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.95e-05	0.00359	CbGpPWpGaD
Betamethasone—Myalgia—Methotrexate—colon cancer	6.9e-05	0.000904	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BAX—colon cancer	6.84e-05	0.00353	CbGpPWpGaD
Betamethasone—Discomfort—Methotrexate—colon cancer	6.81e-05	0.000893	CcSEcCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	6.7e-05	0.00346	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Methotrexate—colon cancer	6.61e-05	0.000867	CcSEcCtD
Betamethasone—Infection—Methotrexate—colon cancer	6.57e-05	0.000861	CcSEcCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	6.52e-05	0.00337	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—EP300—colon cancer	6.51e-05	0.00336	CbGpPWpGaD
Betamethasone—Nervous system disorder—Methotrexate—colon cancer	6.48e-05	0.00085	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—colon cancer	6.47e-05	0.000849	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	6.41e-05	0.00331	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Methotrexate—colon cancer	6.39e-05	0.000838	CcSEcCtD
Betamethasone—Asthenia—Capecitabine—colon cancer	6.37e-05	0.000835	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—colon cancer	6.3e-05	0.000826	CcSEcCtD
Betamethasone—Pruritus—Capecitabine—colon cancer	6.28e-05	0.000824	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—colon cancer	6.18e-05	0.00081	CcSEcCtD
Betamethasone—Diarrhoea—Capecitabine—colon cancer	6.08e-05	0.000797	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—colon cancer	6.02e-05	0.00079	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	5.98e-05	0.00309	CbGpPWpGaD
Betamethasone—Insomnia—Methotrexate—colon cancer	5.98e-05	0.000784	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	5.94e-05	0.00307	CbGpPWpGaD
Betamethasone—Paraesthesia—Methotrexate—colon cancer	5.94e-05	0.000778	CcSEcCtD
Betamethasone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	5.91e-05	0.00305	CbGpPWpGaD
Betamethasone—Dizziness—Capecitabine—colon cancer	5.87e-05	0.00077	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	5.83e-05	0.00301	CbGpPWpGaD
Betamethasone—Dyspepsia—Methotrexate—colon cancer	5.82e-05	0.000763	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	5.77e-05	0.00298	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—HNF4A—colon cancer	5.75e-05	0.00297	CbGpPWpGaD
Betamethasone—Decreased appetite—Methotrexate—colon cancer	5.75e-05	0.000754	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—DLC1—colon cancer	5.72e-05	0.00295	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Methotrexate—colon cancer	5.71e-05	0.000748	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—colon cancer	5.7e-05	0.000747	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	5.69e-05	0.00294	CbGpPWpGaD
Betamethasone—Pain—Methotrexate—colon cancer	5.65e-05	0.000741	CcSEcCtD
Betamethasone—Vomiting—Capecitabine—colon cancer	5.65e-05	0.00074	CcSEcCtD
Betamethasone—Hydrocortisone—ABCB1—colon cancer	5.62e-05	0.088	CrCbGaD
Betamethasone—Rash—Capecitabine—colon cancer	5.6e-05	0.000734	CcSEcCtD
Betamethasone—Dermatitis—Capecitabine—colon cancer	5.59e-05	0.000734	CcSEcCtD
Betamethasone—Headache—Capecitabine—colon cancer	5.56e-05	0.000729	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	5.53e-05	0.00286	CbGpPWpGaD
Betamethasone—Feeling abnormal—Methotrexate—colon cancer	5.45e-05	0.000714	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—colon cancer	5.41e-05	0.000709	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	5.4e-05	0.00279	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	5.39e-05	0.00278	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LGR5—colon cancer	5.38e-05	0.00278	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	5.37e-05	0.00277	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	5.32e-05	0.00275	CbGpPWpGaD
Betamethasone—Nausea—Capecitabine—colon cancer	5.27e-05	0.000692	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—colon cancer	5.25e-05	0.000689	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—CDKN1A—colon cancer	5.25e-05	0.00271	CbGpPWpGaD
Betamethasone—Abdominal pain—Methotrexate—colon cancer	5.23e-05	0.000685	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—colon cancer	5.23e-05	0.000685	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	5.19e-05	0.00268	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	5.13e-05	0.00265	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	5.07e-05	0.00262	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	5.02e-05	0.00259	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—PPARG—colon cancer	5e-05	0.00258	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	4.97e-05	0.00257	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	4.96e-05	0.00256	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—colon cancer	4.92e-05	0.0771	CrCbGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	4.9e-05	0.00253	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	4.85e-05	0.0025	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.84e-05	0.0025	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	4.8e-05	0.00248	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	4.78e-05	0.00247	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	4.77e-05	0.00247	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.77e-05	0.00246	CbGpPWpGaD
Betamethasone—Asthenia—Methotrexate—colon cancer	4.74e-05	0.000622	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	4.73e-05	0.00244	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	4.7e-05	0.00243	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	4.68e-05	0.00242	CbGpPWpGaD
Betamethasone—Pruritus—Methotrexate—colon cancer	4.68e-05	0.000613	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—NRAS—colon cancer	4.67e-05	0.00241	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	4.67e-05	0.00241	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA7—colon cancer	4.65e-05	0.0024	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	4.58e-05	0.00237	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	4.55e-05	0.00235	CbGpPWpGaD
Betamethasone—Diarrhoea—Methotrexate—colon cancer	4.52e-05	0.000593	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—colon cancer	4.37e-05	0.000573	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—EGFR—colon cancer	4.26e-05	0.0022	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ODC1—colon cancer	4.22e-05	0.00218	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CHST5—colon cancer	4.22e-05	0.00218	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	4.2e-05	0.00217	CbGpPWpGaD
Betamethasone—Vomiting—Methotrexate—colon cancer	4.2e-05	0.000551	CcSEcCtD
Betamethasone—Dexamethasone—ABCB1—colon cancer	4.19e-05	0.0656	CrCbGaD
Betamethasone—Rash—Methotrexate—colon cancer	4.17e-05	0.000547	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—colon cancer	4.16e-05	0.000546	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	4.16e-05	0.00215	CbGpPWpGaD
Betamethasone—Headache—Methotrexate—colon cancer	4.14e-05	0.000543	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—KRAS—colon cancer	4.02e-05	0.00208	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	4e-05	0.00207	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.93e-05	0.00203	CbGpPWpGaD
Betamethasone—Nausea—Methotrexate—colon cancer	3.93e-05	0.000515	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.89e-05	0.00201	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AXIN2—colon cancer	3.86e-05	0.00199	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	3.84e-05	0.00198	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	3.82e-05	0.00197	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.79e-05	0.00196	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.75e-05	0.00194	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	3.69e-05	0.00191	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PIK3CA—colon cancer	3.69e-05	0.00191	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	3.67e-05	0.0019	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.63e-05	0.00188	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	3.58e-05	0.00185	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	3.54e-05	0.00183	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—CTNNB1—colon cancer	3.52e-05	0.00182	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—EP300—colon cancer	3.52e-05	0.00182	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HNF4A—colon cancer	3.5e-05	0.00181	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—CDKN1A—colon cancer	3.44e-05	0.00178	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—colon cancer	3.42e-05	0.00176	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	3.38e-05	0.00175	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CHST5—colon cancer	3.36e-05	0.00174	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LGR5—colon cancer	3.36e-05	0.00174	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.34e-05	0.00173	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA7—colon cancer	3.3e-05	0.0017	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	3.29e-05	0.0017	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	3.29e-05	0.0017	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—PPARG—colon cancer	3.16e-05	0.00163	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	3.16e-05	0.00163	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.12e-05	0.00161	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	3.12e-05	0.00161	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—colon cancer	3.06e-05	0.00158	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ABCB1—colon cancer	3.05e-05	0.00158	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	3.04e-05	0.00157	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.02e-05	0.00156	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—AKT1—colon cancer	3.02e-05	0.00156	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TYMS—colon cancer	3e-05	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CASP3—colon cancer	2.99e-05	0.00154	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—colon cancer	2.96e-05	0.00153	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CASP3—colon cancer	2.92e-05	0.00151	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—colon cancer	2.91e-05	0.0015	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	2.89e-05	0.00149	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.89e-05	0.00149	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	2.87e-05	0.00148	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.86e-05	0.00148	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	2.86e-05	0.00148	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—colon cancer	2.84e-05	0.00147	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	2.83e-05	0.00146	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	2.83e-05	0.00146	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CHST5—colon cancer	2.82e-05	0.00145	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ODC1—colon cancer	2.82e-05	0.00145	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	2.8e-05	0.00145	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.79e-05	0.00144	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.68e-05	0.00139	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	2.68e-05	0.00138	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	2.65e-05	0.00137	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PPARG—colon cancer	2.5e-05	0.00129	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.48e-05	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AXIN2—colon cancer	2.42e-05	0.00125	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	2.41e-05	0.00124	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	2.36e-05	0.00122	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—colon cancer	2.33e-05	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	2.33e-05	0.0012	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.31e-05	0.00119	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—colon cancer	2.28e-05	0.00118	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.28e-05	0.00117	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—colon cancer	2.12e-05	0.0011	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.05e-05	0.00106	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.03e-05	0.00105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA7—colon cancer	2.03e-05	0.00105	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HNF4A—colon cancer	2.02e-05	0.00105	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CHST5—colon cancer	2e-05	0.00103	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ODC1—colon cancer	2e-05	0.00103	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.99e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.98e-05	0.00102	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.96e-05	0.00101	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—colon cancer	1.92e-05	0.00099	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.91e-05	0.000989	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.83e-05	0.000943	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	1.83e-05	0.000943	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.82e-05	0.000941	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—colon cancer	1.8e-05	0.00093	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.77e-05	0.000915	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.74e-05	0.000899	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.73e-05	0.000891	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—colon cancer	1.67e-05	0.000862	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.59e-05	0.00082	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.58e-05	0.000818	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.55e-05	0.000802	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.55e-05	0.000802	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—colon cancer	1.52e-05	0.000785	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.47e-05	0.000758	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.44e-05	0.000744	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—colon cancer	1.42e-05	0.000735	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.4e-05	0.000725	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.39e-05	0.000718	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—EP300—colon cancer	1.39e-05	0.000717	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.37e-05	0.000707	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.36e-05	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.35e-05	0.000696	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.3e-05	0.000673	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.29e-05	0.000667	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.26e-05	0.000649	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ODC1—colon cancer	1.23e-05	0.000635	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CHST5—colon cancer	1.23e-05	0.000635	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.22e-05	0.000632	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.16e-05	0.000601	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.14e-05	0.000588	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.13e-05	0.000581	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.12e-05	0.00058	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGFR3—colon cancer	1.12e-05	0.000576	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—colon cancer	1.11e-05	0.000575	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.1e-05	0.000569	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.1e-05	0.000568	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMS—colon cancer	1.09e-05	0.000565	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	1.04e-05	0.000537	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.04e-05	0.000537	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—colon cancer	1.03e-05	0.00053	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—colon cancer	1.02e-05	0.000529	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—colon cancer	9.87e-06	0.00051	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—colon cancer	9.63e-06	0.000497	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.55e-06	0.000493	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.24e-06	0.000477	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—colon cancer	8.79e-06	0.000454	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—colon cancer	8.67e-06	0.000448	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.42e-06	0.000435	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—colon cancer	8.39e-06	0.000433	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.81e-06	0.000403	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—colon cancer	7.75e-06	0.0004	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.61e-06	0.000393	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—colon cancer	7.44e-06	0.000384	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—colon cancer	7.31e-06	0.000378	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—colon cancer	7.22e-06	0.000373	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—colon cancer	7.03e-06	0.000363	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR3—colon cancer	6.98e-06	0.00036	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—colon cancer	6.96e-06	0.000359	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—colon cancer	6.8e-06	0.000351	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—colon cancer	6.47e-06	0.000334	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—colon cancer	6.41e-06	0.000331	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—colon cancer	6.29e-06	0.000325	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—colon cancer	6.13e-06	0.000316	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—colon cancer	6.1e-06	0.000315	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—colon cancer	6.05e-06	0.000312	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—colon cancer	6.02e-06	0.000311	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—colon cancer	6.01e-06	0.00031	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—colon cancer	5.64e-06	0.000291	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.63e-06	0.000291	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—colon cancer	5.62e-06	0.00029	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—colon cancer	5.51e-06	0.000285	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—colon cancer	5.21e-06	0.000269	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—colon cancer	5.18e-06	0.000268	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—colon cancer	5.18e-06	0.000267	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—colon cancer	5.07e-06	0.000262	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—colon cancer	5.01e-06	0.000259	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—colon cancer	4.78e-06	0.000247	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—colon cancer	4.63e-06	0.000239	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—colon cancer	4.43e-06	0.000229	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—colon cancer	4.35e-06	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—colon cancer	4.25e-06	0.00022	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—colon cancer	4.05e-06	0.000209	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—colon cancer	3.93e-06	0.000203	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—colon cancer	3.91e-06	0.000202	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—colon cancer	3.79e-06	0.000195	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—colon cancer	3.75e-06	0.000194	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—colon cancer	3.67e-06	0.00019	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—colon cancer	3.53e-06	0.000182	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—colon cancer	3.52e-06	0.000182	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—colon cancer	3.47e-06	0.000179	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—colon cancer	3.45e-06	0.000178	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—colon cancer	3.39e-06	0.000175	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—colon cancer	3.26e-06	0.000168	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—colon cancer	3.25e-06	0.000168	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—colon cancer	3.19e-06	0.000165	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—colon cancer	3.06e-06	0.000158	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—colon cancer	2.99e-06	0.000155	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—colon cancer	2.89e-06	0.000149	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—colon cancer	2.77e-06	0.000143	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—colon cancer	2.51e-06	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—colon cancer	2.45e-06	0.000126	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—colon cancer	2.4e-06	0.000124	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—colon cancer	2.26e-06	0.000117	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—colon cancer	2.05e-06	0.000106	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—colon cancer	1.78e-06	9.19e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—colon cancer	1.78e-06	9.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—colon cancer	1.48e-06	7.64e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—colon cancer	1.45e-06	7.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—colon cancer	1.09e-06	5.65e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—colon cancer	8.94e-07	4.62e-05	CbGpPWpGaD
